AbbVie announced the U.S. Food and Drug Administration (FDA) approval of VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. VUITY is the first and only FDA-approved eye drop to treat this common and progressive eye condition that affects 128 million Americans, nearly half of the U.S. adult population.
- Read more about USFDA Approves VUITY Only Eye Drop to Treat Presbyopia
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/usfda-approves-vuity-only-eye-drop-to-treat-presbyopia
No comments:
Post a Comment